Table 3-.
Transplant outcomes
| Variable | Chemo-mobilized Cohort N=117 | Matched cohort N=117 | P value |
|---|---|---|---|
| Days to neutrophil engraftment, median (range) | 16 (11–26) | 15 (10–29) | 0.27 |
| Days to platelets engraftment (50000), median (range) | 16 (11–64) | 16 (11–42) | 0.22 |
| Bacteremia, n (%) | 27 (23) | 22 (19) | 0.52 |
| Hospitalizations, n (%) | 57 (49) | 59 (51) | 0.9 |
| Infection | 20 (35) | 26 (41) | |
| Cardiac arrhythmia | 8 (14) | 1 (2) | |
| Dehydration | 17 (30) | 20 (32) | |
| Others | 12 (21) | 16 (25) | |
| Days in hospital of those hospitalized, median (IQR) | 7 (5–12) | 8 (5–12) | 0.95 |
| Need for RBC transfusion during ASCT, n (%) | 79 (75) | 55 (47) | <0.001 |
| Need for PLT transfusion during ASCT, n (%) | 95 (88) | 101 (86) | 0.7 |
| Neutropenic fever, n (%) | 64 (58) | 70 (60) | 0.89 |
| Mucositis, n (%) | 39 (33) | 36 (31) | 0.77 |
n=number; IQR=interquartile range.